Fresh Recalls

Cetirizine Hydrochloride Tablets USP 5 mg: recall status

Notice names this product. JB Chemicals and Pharmaceuticals’s Cetirizine Hydrochloride Tablets USP 5 mg is named in FDA Class I recall D-0732-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine. Identifying details: Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT. Units affected: 34,020 100-count bottles.. Status: Ongoing.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Cetirizine Hydrochloride Tablets USP 5 mg
Company / brand
JB Chemicals and Pharmaceuticals
Lot / serial / date codes
Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT
Distribution
Nationwide in the USA
Agency product description and boundaries

Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

Brand
JB Chemicals and Pharmaceuticals

Recalls naming this model

FDA Class I · Drug · July 29, 2026

Cetirizine Hydrochloride Tablets USP 5 mg recall — JB Chemicals and Pharmaceuticals Ltd

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to …

Company / brand: JB Chemicals and Pharmaceuticals

Affected product: Cetirizine Hydrochloride Tablets USP 5 mg

Official ID D-0732-2026 · Official record ↗

See all JB Chemicals and Pharmaceuticals recalls →

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.